Myoung-Taek Choi

This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Ophthalmic Lenses. Top assignees: Alcon, Inc., Novartis Ag, University of Central Florida Research Foundation Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myoung-Taek Choi. Retrieved from https://idiyas.com/inventor/myoung-taek-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 13)

% Patents Active = 94.7

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 102(Granted Patents)

Company Filing History:

University of Central Florida Research Foundation Inc.

patents

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Multifocal Lens

Chromatic Aberrations

Visual Disturbances

Extended Depth of Focus

Diffractive Lens

Intraocular Lens

Pseudo-Accommodation

Phase Shift

Ultralow Noise Laser

Pupil Dynamics

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502269 - Multifocal lens having reduced chromatic aberrations (2025-12-23),

2. 12396842 - Ophthalmic lenses having an extended depth of focus for improving intermediate vision (2025-08-26),

3. 12161550 - Multifocal lens having reduced visual disturbances (2024-12-10),

4. 11903819 - Ophthalmic lenses having an extended depth of focus for improving intermediate vision (2024-02-20),

5. 11813160 - Multifocal lens having reduced visual disturbances (2023-11-14),

6. 11684469 - Multifocal lens having reduced chromatic aberrations (2023-06-27),

7. 11364111 - Multifocal lens having reduced visual disturbances (2022-06-21),

8. 11000366 - Multifocal diffractive ophthalmic lens (2021-05-11),

9. 11000365 - Multifocal diffractive ophthalmic lens using suppressed diffractive order (2021-05-11),

10. 10993798 - Multifocal lens having reduced chromatic aberrations (2021-05-04),

11. 10675146 - Multifocal lens having reduced visual disturbances (2020-06-09),

12. 10426599 - Multifocal lens having reduced chromatic aberrations (2019-10-01),

13. 10285806 - Multifocal diffractive ophthalmic lens (2019-05-14),

14. 10278811 - Multifocal diffractive ophthalmic lens using suppressed diffractive order (2019-05-07),

15. 9335564 - Multifocal diffractive ophthalmic lens using suppressed diffractive order (2016-05-10),

Title: Myoung-Taek Choi: Innovator in Ophthalmic Lens Technology

Introduction

Myoung-Taek Choi is a prominent inventor based in Arlington, TX (US), known for his significant contributions to ophthalmic lens technology. With a total of 18 patents to his name, Choi has made remarkable advancements in improving vision through innovative lens designs.

Latest Patents

Choi's latest patents include groundbreaking inventions such as ophthalmic lenses designed to enhance depth of focus for intermediate vision. This particular lens features an optic with an anterior and posterior surface, where the anterior surface incorporates a complex profile that includes a base structure, a phase shift structure, and a zonal structure. Another notable patent is for a multifocal lens that minimizes visual disturbances. This lens utilizes a diffractive structure and base curvature to create two distinct spherical aberrations, enhancing the overall visual experience for users.

Career Highlights

Throughout his career, Myoung-Taek Choi has worked with leading companies in the field, including Alcon, Inc. and Novartis AG. His work has significantly impacted the development of advanced ophthalmic devices, showcasing his expertise and dedication to innovation in vision correction.

Collaborations

Choi has collaborated with talented individuals such as Xin Hong and Yueai Liu, contributing to the advancement of ophthalmic technologies through teamwork and shared expertise.

Conclusion

Myoung-Taek Choi's innovative work in ophthalmic lens technology has led to significant advancements in vision correction. His patents reflect a commitment to enhancing the quality of life for individuals with vision impairments.

Profile summary based on public USPTO records.